Consensus Valerio Therapeutics London S.E.

Equities

0NWK

FR0010095596

Market Closed - London S.E. Other stock markets 04:48:08 30/11/2020 pm IST			5-day change	1st Jan Change
0.7551 ^EUR	-0.52%		+514.40%	+335.72%

22/05	Valerio Therapeutics S.A. Provides Clinical Development Update on Its Phase 1/2 VIO-01 Clinical Trial	CI
30/04	Valerio Therapeutics Société anonyme Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Evolution of the average Target Price on Valerio Therapeutics

Price target over the last 5 years

History of analyst recommendation changes

88f04ede99cade01fb19.s2aF8E79gYEQ0iSTCP7WkRDOE5ufV4JPd2nITLDsTDM.gjWzxzmO1LA9hGr2UY6RyHa9KsLND8MfTjz9JumaJVCeX820BMq190anQw~39a05237a5a477bc15eb5c94d8722a60

Analyst Recommendations on Valerio Therapeutics

Onxeo : Bryan Garnier & Co initiates the coverage of Onxeo with a “Buy” recommendation	29/20/29	PU
Bryan Garnier & Co Initiates Coverage of Onxeo with a “Buy” Recommendation	27/20/27	GL
Onxeo : Bryan Garnier & Co Initiates the Coverage of Onxeo with a “Buy” Recommendation	27/20/27	BU

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

0.106 EUR

Average target price

1.2 EUR

Spread / Average Target

+1,032.08%

High Price Target

1.2 EUR

Spread / Highest target

+1,032.08%

Low Price Target

1.2 EUR

Spread / Lowest Target

+1,032.08%

Consensus detail

Consensus revision (last 18 months)

Annual profits - Rate of surprise

Company calendar